Open-label, Single-center Study in Healthy Subjects to Investigate the Effect of Oral Givinostat on Pharmacokinetics (PK) of Intravenous and Oral Midazolam and Oral Dabigatran Etexilate (PART 1)
Latest Information Update: 09 Jan 2025
At a glance
- Drugs Dabigatran etexilate (Primary) ; Givinostat (Primary) ; Midazolam (Primary) ; Midazolam (Primary)
- Indications Duchenne muscular dystrophy; Myeloproliferative disorders; Polycythaemia vera
- Focus Pharmacokinetics
- Sponsors Italfarmaco
Most Recent Events
- 06 Jan 2025 Protocol has been amended to include changes in treatment arms, endpoints, study design and patient number.
- 06 Jan 2025 Protocol has been amended to include changes in treatment arms, endpoints, study design and patient number.
- 12 Aug 2022 New trial record